Form 483

Patheon UK Limited Form 483, 2015-05-08

FDA issued a Form 483 to Patheon UK Limited on 2015-05-08 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Patheon UK Limited · Swindon, United Kingdom · Issued May 8, 2015

Overview

  • 6 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 May 2015
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Marcus F Yambot

8 May 2015
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Marcus F Yambot

8 May 2015
21 CFR 211.94(a)

Reactive/Additive/Absorptive Containers/Closures

Cited by Marcus F Yambot

8 May 2015
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Marcus F Yambot

8 May 2015
21 CFR 211.42(c)(10)(iv)

Environmental Monitoring System

Cited by Marcus F Yambot

Inspected site

PUPatheon UK LimitedSwindon, United Kingdom

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations2x
21 CFR 211.42(c)(10)(iv)Cited across public-safe Form 483 observations2x
21 CFR 211.94(a)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere